Elsevier BV

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Eastham
    Eastham
  3. Touijer
    Touijer
  4. Benfante
    Benfante
  5. Ehdaie
    Ehdaie
  6. Motzer
    Motzer
  7. Riely
    Riely
  8. Russo
    Russo
  9. Solomon
    Solomon
  10. Vertosick
    Vertosick

Groups

  1. Department of Medicine (48)
  2. Surgery (42)
  3. Population Sciences Research Program (39)
  4. Solid Tumor Oncology Division (38)
  5. Epidemiology and Biostatistics (37)
  6. Urology (32)
  7. Survivorship Research (24)
  8. Health Outcomes Research Group (21)
  9. Genitourinary Oncology Service (20)
  10. Sloan Kettering Institute Postdocs (19)
Search Within
Formats
  1. Journal Article (94)
  2. Review (15)
  3. Editorial (9)
  4. Research Letter (5)
  5. Conference Paper (1)
  6. Correspondence (1)
  7. Guidelines (1)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (48)
  2. Surgery (42)
  3. Population Sciences Research Program (39)
  4. Solid Tumor Oncology Division (38)
  5. Epidemiology and Biostatistics (37)
  6. Urology (32)

More Groups

People
  1. Andrew Vickers (15)
  2. James Eastham (7)
  3. Karim Touijer (7)
  4. Behfar Ehdaie (6)
  5. Daniel Sjoberg (6)
  6. Nicole Benfante (6)

More People

Years
  1. 2025 (8)
  2. 2024 (18)
  3. 2023 (24)
  4. 2022 (18)
  5. 2021 (14)
  6. 2020 (16)

More Years

Publications
  1. European Urology Oncology (45)
  2. JTO Clinical and Research Reports (19)
  3. European Urology Open Science (15)
  4. JAAD International (5)
  5. Integrative Medicine Research (4)
  6. Journal of Cancer Policy (4)

More Publications

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequencing and combination of systemic therapy in metastatic renal cell carcinoma
    Review

    de Velasco, G.; Bex, A.; Albiges, L.; Powles, T.; Rini, B. I.; Motzer, R. J.; Heng, D. Y. C.; Escudier, B.
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Consistent biopsy quality and Gleason grading within the Global Active Surveillance Global Action Plan 3 initiative: A prerequisite for future studies
    Journal Article

    van der Kwast, T. H.; Helleman, J.; Nieboer, D.; Bruinsma, S. M.; Roobol, M. J.; The Movember Foundations Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Modeling 1-year relapse-free survival after neoadjuvant chemotherapy and radical cystectomy in patients with clinical T2-4N0M0 urothelial bladder carcinoma: Endpoints for phase 2 trials
    Journal Article

    Bandini, M.; Briganti, A.; Plimack, E. R.; Niegisch, G.; Yu, E. Y.; Bamias, A.; Agarwal, N.; Sridhar, S. S.; Sternberg, C. N.; Vaishampayan, U.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • ETS rearrangements, neuroendocrine modulators, and androgen resistance: What can the microenvironment reveal in prostate cancer?
    Editorial

    Singla, N.
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Electroporation-induced changes in tumor vasculature and microenvironment can promote the delivery and increase the efficacy of sorafenib nanoparticles
    Journal Article

    Kodama, H.; Shamay, Y.; Kimura, Y.; Shah, J.; Solomon, S. B.; Heller, D.; Srimathveeravalli, G.
    Bioelectrochemistry (2019)

    Fulltext@MSK | Save
  • A systematic review of the role of definitive local treatment in patients with clinically lymph node-positive prostate cancer
    Journal Article

    Ventimiglia, E.; Seisen, T.; Abdollah, F.; Briganti, A.; Fonteyne, V.; James, N.; Roach, M. 3rd; Thalmann, G. N.; Touijer, K.; Chen, R. C.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • When oncologic treatment options outpace the existing evidence: Contributing factors and a path forward
    Guidelines

    van der Velden, D. L.; Levit, L. A.; Chang, G. J.; Facktor, M. A.; Goodman, K. A.; Kaufman, J.; Konecny, G. E.; Kwan, S. W.; Mooney, M.; Smith, G.; more...
    Journal of Cancer Policy (2019)

    Fulltext@MSK | Save
  • Kidney cancer and surgical metastasectomy: Effective therapy or part of disease natural history?
    Editorial

    Russo, P.
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Prospective study of the radiolabeled GRPR antagonist BAY86-7548 for positron emission tomography/computed tomography imaging of newly diagnosed prostate cancer
    Journal Article

    Touijer, K. A.; Michaud, L.; Alvarez, H. A. V.; Gopalan, A.; Kossatz, S.; Gonen, M.; Beattie, B.; Sandler, I.; Lyaschenko, S.; Eastham, J. A.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Functional and oncologic outcomes between open and robotic radical prostatectomy at 24-month follow-up in the Swedish LAPPRO Trial
    Journal Article

    Nyberg, M.; Hugosson, J.; Wiklund, P.; Sjoberg, D.; Wilderäng, U.; Carlsson, S. V.; Carlsson, S.; Stranne, J.; Steineck, G.; Haglind, E.; more...
    European Urology Oncology (2018)

    Fulltext@MSK | Save

    • Elsevier BV – authorized name for: